Proceedings of the American Thoracic Society Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

The Proceedings of the American Thoracic Society 4:343-346 (2007)
© 2007 The American Thoracic Society
doi: 10.1513/pats.200611-174HT
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tiddens, H. A. W. M.
Right arrow Articles by de Jong, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tiddens, H. A. W. M.
Right arrow Articles by de Jong, P. A.

Imaging and Clinical Trials in Cystic Fibrosis

Harm A. W. M. Tiddens1 and Pim A. de Jong1,2

1 Department of Pediatric Pulmonology and Allergology, Erasmus MC–Sophia Children's Hospital, Rotterdam, The Netherlands; and 2 Department of Radiology, Meander Medical Center, Amersfoort, The Netherlands

Correspondence and requests for reprints should be addressed to Harm A.W.M. Tiddens, M.D., Ph.D., Erasmus MC–Sophia Children's Hospital, Department of Pediatric Pulmonology and Allergology, P.O Box 2060, 3000CB Rotterdam, The Netherlands. E-mail: h.tiddens{at}erasmusmc.nl

ABSTRACT

Lung function parameters have been used in most therapeutic studies to date. Thanks to improvements in cystic fibrosis (CF) therapy, these parameters have become a less sensitive endpoint in clinical studies. Computed tomography (CT) in CF can identify highly relevant structural lung changes, such as bronchiectasis and air trapping. CT scoring systems have been developed to quantify in a systematic fashion these structural changes on CT scans. Clinical studies have been conducted using CT scores as an outcome parameter. These studies suggest strongly that CT scoring is more sensitive than pulmonary function tests for the detection of relevant disease progression in CF. Bronchiectasis, which is progressive and irreversible in CF, is probably the most relevant structural change on CT scans that can be scored reliably. CT measurement of airway wall thickening is possible. Airway wall thickening is related to inflammation; thus, this endpoint is of significance for interventional studies that include antiinflammatory drugs.

Key Words: computed tomography • endpoint • structure function • cystic fibrosis • bronchiectasis






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Thoracic Society. 		 
Red Transition